slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 2,641-2,670
Pages 3,225
Rows per page 30
Component
2,641-2,670 of 96,741
46
The slide uses legal filings and OIG reports to establish a pattern of billing abuse in the sleep sector.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle3 hits
75
The slide uses a 'before-after' narrative structure to show that shifting chemical scaffolds did not solve the underlying safety issues in H3 receptor drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
101
The slide uses Q&A format to highlight potential industry knowledge of safety risks that were not publicly disclosed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
103
The slide presents two distinct expert critiques regarding IP expiration and clinical trial quality, attributed to a senior scientist at Johnson & Johnson.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
122
The slide uses a 'before-after' or 'comparison' logic to expose data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
130
The slide uses direct citations from FDA and research documents to highlight the discrepancy between single-dose study designs and the need for steady-state peak plasma concentration analysis.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
150
The slide uses a specific calculation (153 ng/mL * 4 * 2 = 1224 ng/mL) to quantify risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
164
The slide uses a combination of original analysis and cited medical literature to challenge the transparency of clinical trial reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
224
The slide uses a 'red flag' argument to suggest data manipulation or p-hacking via sample size adjustment.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
231
The slide uses a 'villain' framing for the FDA reviewer's oversight.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
307
The slide uses a combination of narrative argument and direct excerpts from regulatory documents to highlight a discrepancy in drug efficacy claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
352
The slide uses highlighted text to emphasize key allegations of regulatory non-compliance and unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
361
The slide uses highlighted text to emphasize key claims about PIPs and quota misalignment.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
89
The slide uses direct quotes to undermine the company's technological claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
94
Uses yellow highlighting to emphasize key critical claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
107
Uses expert testimony to undermine the company's technical roadmap.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
129
The slide uses direct quotes from a former senior scientific employee to undermine the company's technical roadmap.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
168
Uses red circles and arrows to highlight specific text and images as evidence of contradiction.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
181
The slide uses visual callouts (red circles and arrows) to point out the specific text segments being compared.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
182
This is an activist short-seller deck slide attacking the credibility of a CEO.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
49
The slide uses a direct visual comparison of financial charts to highlight a lack of transparency in Lasertec's reporting compared to industry peer ASML.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products3 hits
52
The slide uses two charts to contrast conflicting analyst reports, illustrating the uncertainty in Lasertec's revenue composition.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's productsLoop · The Reveal3 hits
87
The slide uses excerpts from 10K filings to show that auditors are flagging inventory valuation as a 'critical audit matter' due to management judgment, implying potential risk despite no explicit fraud findings.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 3 hits
100
The slide argues that Lasertec's inventory inflation masks a massive potential impairment that would wipe out a significant portion of historical profits and retained earnings, comparing the scale to the Toshiba accounting scandal.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 3 hits
123
The slide consists of two distinct blocks of text, each attributed to an expert in extreme ultraviolet lithography, detailing Intel's shifting narrative on supplier quality.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 3 hits
142
The slide uses red boxes and arrows to highlight key technical improvements (Urashima light source and High-NA support) within the original English press release text.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action3 hits
156
The slide presents a narrative of corporate inconsistency and potential deception regarding technical performance.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 3 hits
82
The slide uses expert testimony to undermine the company's core value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory3 hits
209
The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 3 hits
63
Includes a callout box with highlighted text emphasizing the lack of evidence for the breakthrough.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits